Dr. Cameron Twitty focuses his practice on U.S. and foreign patent prosecution and freedom-to-operate analysis in the field of chemistry, specifically organic chemistry, medicinal chemistry, and organometallic chemistry. Cameron’s experience includes a broad range of innovations including small molecule and small molecule degraders, antibody drug conjugates, polymer compositions, and experimental methods and devices.
Cameron earned his PhD in organic chemistry from the University of Delaware, where his research focused on the development of novel synthetic methods for use in the chemical and pharmaceutical industry. His graduate research specifically focused on the development of nickel-catalyzed cross couplings that afford pharmaceutically relevant products from feedstock chemicals such as amines and alcohols. During his tenure at the University of Delaware, Cameron was also a member of the NIH-funded Chemical-Biology Interface program and supported the High-Throughput Experimentation Facility, where he gained experience across a variety of research topics, such as biochemistry, computational chemistry, electrochemistry, and chromatography.
Prior to obtaining his PhD, Cameron obtained his BS in chemistry from the College of Charleston, where he completed undergraduate research in the field organic chemistry.